# Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework

> **NCT07171814** · — · NOT_YET_RECRUITING · sponsor: **Lianxin Wang** · enrollment: 266 (estimated)

## Conditions studied

- Premenstrual Syndrome

## Interventions

- **DRUG:** Honghua Xiaoyao tablets

## Key facts

- **NCT ID:** NCT07171814
- **Lead sponsor:** Lianxin Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2025-09-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07171814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07171814, "Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07171814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*